Familial cortical myoclonus with a mutation in NOL3

Annals of Neurology

Volumn 72, Issue 2, 2012, Pages 175-183

  Russell, Jonathan F ^a   Steckley, Jamie L ^b,g   Coppola, Giovanni ^c   G Hahn, Angelika F ^b   Howard, MacKenzie A ^a   Kornberg, Zachary ^a   Huang, Alden ^c   Mirsattari, Seyed M ^b   Merriman, Barry ^c   Klein, Eric ^c   Choi, Murim ^d   Lee, Hsien Yang ^a   Kirk, Andrew ^e   Nelson Williams, Carol ^d   Gibson, Gillian ^f   Baraban, Scott C ^a   Lifton, Richard P ^d   Geschwind, Daniel H ^c   Fu, Ying Hui ^a   Ptáček, Louis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL UNIVERSITY HOSPITAL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g GRAND RIVER HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NOL3 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN CORTEX; CEREBELLAR ATAXIA; CHROMOSOME 16Q; CHROMOSOME 16Q21; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EVOKED SOMATOSENSORY RESPONSE; FAMILIAL CORTICAL MYOCLONUS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOMICS; HUMAN; IN VITRO STUDY; MALE; MOUSE; MYOCLONUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CANADA; CELL LINE, TRANSFORMED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; ELECTROENCEPHALOGRAPHY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; HUMANS; MALE; MICE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; MYOCLONUS; PHENOTYPE; PROLINE; TRANSFECTION;

EID: 84865605169     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23666     Document Type: Article

References (29)

1. Shibasaki H, Hallett M,. Electrophysiological studies of myoclonus. Muscle Nerve 2005; 31: 157-174. (Pubitemid 40189837)
2. Caviness J, Brown P,. Myoclonus: current concepts and recent advances. Lancet Neurol 2004; 3: 598-607. (Pubitemid 39221926)
3. Uyama E, Fu YH, PtaÂček L,. Familial adult myoclonic epilepsy (FAME). Adv Neurol 2005; 95: 281-288.
4. Plaster NM, Uyama E, Uchino M, et al. Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24. Neurology 1999; 53: 1180-1183. (Pubitemid 29480072)
5. Striano P, Zara F, Striano S,. Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand 2005; 111: 211-217. (Pubitemid 40380454)
6. Depienne C, Magnin E, Bouteiller D, et al. Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p. Neurology 2010; 74: 2000-2003.
7. Grimes DA, Han F, Lang AE, et al. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002; 59: 1183-1186. (Pubitemid 35192387)
8. Roze E, Apartis E, Clot F, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008; 70: 1010-1016. (Pubitemid 351451308)
9. Nardocci N, Zorzi G, Barzaghi C, et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 2008; 23: 28-34. (Pubitemid 351281214)
10. Li J, Cunic D, Paradiso G, et al. Electrophysiological features of myoclonus-dystonia. Mov Disord 2008; 23: 2055-2061.
11. Marelli C, Canafoglia L, Zibordi F, et al. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord 2008; 23: 2041-2048.
12. Koseki T, Inohara N, Chen S, Núñez G,. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A 1998; 95: 5156-5160. (Pubitemid 28208567)
13. Shojaee S, Sina F, Banihosseini SS, et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500K SNP arrays. Am J Hum Genet 2008; 82: 1375-1384.
14. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009; 27: 182-189.
15. Choi M, Scholl U, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 2009; 106: 19096-19101.
16. Gabriel S, Ziaugra L, Tabbaa D,. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009; 60: 2.12.1-2.12.18.
17. Engidawork E, Gulesserian T, Yoo BC, et al. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 2001; 281: 84-93. (Pubitemid 32924403)
18. Gulesserian T, Engidawork E, Yoo BC, et al. Alteration of caspases and other apoptosis regulatory proteins in Down syndrome. J Neural Transm Suppl 2001;(61): 163-179. (Pubitemid 38085080)
19. Shelke RR, Leeuwenburgh C,. Lifelong caloric restriction increases expression of apoptosis repressor with a caspase recruitment domain (ARC) in the brain. FASEB J 2003; 17: 494-496.
20. Chou JJ, Matsuo H, Duan H, Wagner G,. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 1998; 94: 171-180. (Pubitemid 28348005)
21. Zhou P, Chou J, Olea RS, et al. Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. Proc Natl Acad Sci U S A 1999; 96: 11265-11270. (Pubitemid 29487369)
22. Donath S, Li P, Willenbockel C, et al. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 2006; 113: 1203-1212.
23. Marseille Consensus Group. Classification of progressive myoclonic epilepsies and related disorders. Ann Neurol 1990; 28: 113-116.
24. Matsumoto J, Fuhr P, Nigro M, Hallett M,. Physiological abnormalities in hereditary hyperekplexia. Ann Neurol 1992; 32: 41-50.
25. Olsen JV, Vermeulen M, Santamaria A, et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010; 3: ra3.
26. Li PF, Li J, Müller EC, et al. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell 2002; 10: 247-258. (Pubitemid 35007340)
27. Tan WQ, Wang JX, Lin ZQ, et al. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation 2008; 118: 2268-2276.
28. Lu X, Moore PG, Liu H, Schaefer S,. Phosphorylation of ARC is a critical element in the antiapoptotic effect of anesthetic preconditioning. Anesth Analg 2011; 112: 525-531.
29. Park H, Kim JI, Ju YS, et al. Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing. Nat Genet 2010; 42: 400-405.